Dharminder Chahal

CEO and Founder, SkylineDx & Investment Manager, Van Herk Investments

Dharminder has an extensive network in the life science industry and holds a strong track record in direct involvement of complex corporate transactions. These include the sale of the stake of Van Herk Investments in Crucell to Johnson and Johnson, deVGen to Syngenta and Octoplus to Dr. Reddy’s. Indirectly, with Van Herk Investments as important shareholder, he was involved in the recent sale of Ablynx to Sanofi and the deal between Galapagos and Gillead. Furthermore, he is CEO and founder of SkylineDx, fund manager at Swanbridge Capital and active for several companies as board member or advisor.

Marcel Levi
University College London Hospitals

Jan van de Winkel
Genmab

Annemarie Jorritsma
NVP

Ton Rijnders
Lygature & Oncode Institute

Koen Kas
UGhent & HealthSkouts

Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix

Claudia Rijcken
pharmi

Inge Huitinga
Netherlands Brain Bank

Wiro Niessen
Erasmus MC, TU Delft & Quantib

Els Beirnaert
Aelin Therapeutics

Joep Muijrers
PureTech Health

Koenraad Wiedhaup
McKinsey & Company

Esther Talboom-Kamp
Saltro Diagnostics

Elise Meijer
Antwerp Management School & Accenture Strategy

Carine van den Brink
Axon Lawyers

Tim Knotnerus
AgomAb Therapeutics

Sjaak Vink
TheSocialMedwork

Hans Schikan
Topsector Life Sciences & Health

Thijn Brummelkamp
Scenic Biotech

Nadine Rouleaux
Maastricht University

Charlotte Kluit
MSD

Dharminder Chahal
SkylineDx, Van Herk Investments, Swanbridge

Marianne van der Steen
RegMedXB & Maastricht University

Jan de Kerpel
Kempen & Co

Wim Van Hecke
icoMetrix

Wiesje van der Flier
Alzheimercentrum Amsterdam

Niels Prins
Brain Research Center & Alzheimercentrum Amsterdam

Marco Blom
Alzheimer Nederland

Edwin Moses
Achilles Therapeutics & Evox Therapeutics

Carl Moons
Health Innovation Initiative Holland

Jan Kimpen
Philips

Linda van de Burgwal
Vrije Universiteit Amsterdam

Onno van de Stolpe
Galapagos

Ton van der Steen
Erasmus MC, Medical Delta & STW

Sangbreeta Moitra
Founder, International Keynote Speaker & Global Strategist

Eline Vrijland-van Beest
NightBalance & Philips

Kim Peters
Healthnovum

Gideon Bevelander
Johnson & Johnson Innovation

Giuseppe Marzio
Chiaro

Wijnand IJsselsteijn
Eindhoven University of Technology

Francesco De Rubertis
Medicxi

André van de Sande
André van de Sande Consultancy BV

Travis McCready
President and CEO, Massachusetts Life Sciences Center

Kees van der Klauw
e/MTIC & NL AI Coalition

Maroeska Rovers
Health Innovation Initiative Holland

Christina Takke
V-Bio Centures

Focco Vijselaar
Ministerie van Economische Zaken en Klimaat

Juliette Audet
Forbion

Felice Verduyn
LSP

Kayvan Kian
McKinsey & Company

Thijs Cohen Tervaert
INKEF

Tjarda Molenaar
NVP

Willemijn Vader
VitroScan B.V.

Thomas Hankemeier
Leiden University

Henk-Jan Guchelaar
Leiden University Medical Center

Jos Lunenberg
ENPICOM BV

Peter de With
Eindhoven University of Technology

Natal van Riel
Eindhoven University of Technology

Bart van Zijll Langhout
Janssen Strategic Alliances EMEA & Janssen NL Campus Lead

Jan Peter Balkenende
Former Prime Minister

Elena Fernandez-Kleinlein
JLABS EMEA

Robert Vries
Hubrecht Organoid Technology

Peter Roevens
Janssen Pharmaceutica NV

Stefan Luzi
Gilde Healthcare

Peter Haasjes
Nextgenventures

Brigitte Drees
Pivot Park

Femke van de Hoef
Loyens & Loeff

Dries Fransen van de Putte
Loyens & Loeff

Rob de Ree
Biogeneration Ventures